Literature DB >> 2204317

The role of graft-derived dendritic leukocytes in the rejection of vascularized organ allografts. Recent findings on the migration and function of dendritic leukocytes after transplantation.

C P Larsen1, J M Austyn, P J Morris.   

Abstract

Dendritic cells isolated from lymphoid tissues are potent stimulators of primary allogeneic T-cell responses in vitro and in vivo. Similar major histocompatibility complex class II-bearing dendritic-shaped leukocytes are contained within transplanted organs and these are thought to be important passenger leukocytes that trigger rejection. Recent findings on the migration, phenotype, and function of cardiac dendritic leukocytes (DLs) are reviewed. After transplantation donor DLs migrate rapidly from mouse cardiac allografts into the recipients's spleens. Within the spleens donor DLs associate with recipient CD4+ T cells. Isolated cardiac DLs, like lymphoid dendritic cells, are potent stimulators of T-cell proliferation in vitro. This suggests that DLs function as passenger leukocytes by migrating from grafts into the lymphoid tissues of the recipient and that sensitization to vascularized organ allografts may occur centrally within lymphoid tissues rather than peripherally in the graft itself.

Entities:  

Mesh:

Year:  1990        PMID: 2204317      PMCID: PMC1358162          DOI: 10.1097/00000658-199009000-00009

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  50 in total

1.  Depletion of donor Ia+ cells before transplantation does not prolong islet allograft survival.

Authors:  P F Gores; D E Sutherland; J L Platt; F H Bach
Journal:  J Immunol       Date:  1986-09-01       Impact factor: 5.422

2.  Pretreatment of human renal allografts with monoclonal antibodies to induce long-term tolerance.

Authors:  D Taube; K I Welsh; M Bewick; F E Dische; A Palmer; V Parsons; S Snowden
Journal:  Transplant Proc       Date:  1987-02       Impact factor: 1.066

3.  Lack of effect of splenectomy on the influence of pretransplant blood transfusions on cardiac allograft survival in histoincompatible rats.

Authors:  R Pollak; J M Blanchard; M F Mozes
Journal:  Transplantation       Date:  1986-04       Impact factor: 4.939

4.  Presentation of alloantigens by host cells.

Authors:  R A Sherwood; L Brent; L S Rayfield
Journal:  Eur J Immunol       Date:  1986-05       Impact factor: 5.532

Review 5.  Effector mechanisms in allograft rejection.

Authors:  D W Mason; P J Morris
Journal:  Annu Rev Immunol       Date:  1986       Impact factor: 28.527

6.  Donor-type MHC-positive cells in the host spleen after rat organ transplantation. Differences between pancreas and heart allograft recipients.

Authors:  B Steiniger; J Klempnauer
Journal:  Transplantation       Date:  1986-06       Impact factor: 4.939

7.  Occurrence of donor Langerhans cells in mouse and rat chimeras and their replacement in skin grafts.

Authors:  H D Chen; C L Ma; J T Yuan; Y K Wang; W K Silvers
Journal:  J Invest Dermatol       Date:  1986-06       Impact factor: 8.551

8.  Long-term effect of splenectomy versus no splenectomy in renal transplant patients. Reanalysis of a randomized prospective study.

Authors:  D E Sutherland; D S Fryd; S K So; F R Bentley; N L Ascher; R L Simmons; J S Najarian
Journal:  Transplantation       Date:  1984-12       Impact factor: 4.939

9.  Massive induction of donor-type class I and class II major histocompatibility complex antigens in rejecting cardiac allografts in the rat.

Authors:  A D Milton; J W Fabre
Journal:  J Exp Med       Date:  1985-01-01       Impact factor: 14.307

10.  Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro.

Authors:  G Schuler; R M Steinman
Journal:  J Exp Med       Date:  1985-03-01       Impact factor: 14.307

View more
  25 in total

Review 1.  Interstitial nephritis.

Authors:  S Dhillon; R M Higgins
Journal:  Postgrad Med J       Date:  1997-03       Impact factor: 2.401

2.  The basis of allograft acceptance.

Authors:  Thomas E Starzl
Journal:  Forum (Genova)       Date:  1997

3.  Visualizing the innate and adaptive immune responses underlying allograft rejection by two-photon microscopy.

Authors:  Susanna Celli; Matthew L Albert; Philippe Bousso
Journal:  Nat Med       Date:  2011-05-15       Impact factor: 53.440

Review 4.  The future of transplantation: with particular reference to chimerism and xenotransplantation.

Authors:  T E Starzl; A J Demetris; N Murase; L Valdivia; A W Thomson; J Fung; A S Rao
Journal:  Transplant Proc       Date:  1997 Feb-Mar       Impact factor: 1.066

Review 5.  The role of cell migration and microchimerism in the induction of tolerance after solid organ transplantation.

Authors:  R M Jindal; A Sahota
Journal:  Postgrad Med J       Date:  1997-03       Impact factor: 2.401

Review 6.  Emerging role of exosomes in allorecognition and allograft rejection.

Authors:  Bruno Gonzalez-Nolasco; Mengchuan Wang; Aurore Prunevieille; Gilles Benichou
Journal:  Curr Opin Organ Transplant       Date:  2018-02       Impact factor: 2.640

7.  Low energy X-ray (grenz ray) treatment of purified islets prior to allotransplant markedly decreases passenger leukocyte populations.

Authors:  Rena Pawlick; Boris Gala-Lopez; Andrew R Pepper; Nasser Abualhassan; Antonio Bruni; Kunimasa Suzuki; Gina Rayat; John F Elliott; A M James Shapiro
Journal:  Islets       Date:  2017-07-10       Impact factor: 2.694

Review 8.  Immune recognition and rejection of allogeneic skin grafts.

Authors:  Gilles Benichou; Yohei Yamada; Seok-Hyun Yun; Charles Lin; Michael Fray; Georges Tocco
Journal:  Immunotherapy       Date:  2011-06       Impact factor: 4.196

Review 9.  Microchimerism in promoting graft acceptance in clinical transplantation.

Authors:  James M Mathew; Joseph R Leventhal; Joshua Miller
Journal:  Curr Opin Organ Transplant       Date:  2011-08       Impact factor: 2.640

Review 10.  Mechanism of cellular rejection in transplantation.

Authors:  Elizabeth Ingulli
Journal:  Pediatr Nephrol       Date:  2010-01       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.